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Abstract 
Aim: To evaluate the effect of abdominal radical trachelectomy on ovarian reserve and 
compare it with abdominal radical hysterectomy and a control group that did not have sur-
gery. 
Method: We enrolled eighteen women who had abdominal radical trachelectomy with pelvic 
lymphadenectomy and sixteen patients who had abdominal radical hysterectomy for this 
study. Ten thousand one hundred eighty-six women were also included as a control group for 
comparison. The Mann-Whitney U test was used for comparison of patient characteristics and 
comparison of serum anti-Müllerian hormone levels between the three groups. 
Results: Serum anti-Müllerian hormone levels in patients with abdominal radical trachelec-
tomy were significantly higher than those of patients with abdominal radical hysterectomy 
(P<0.05). Serum anti-Müllerian hormone levels in the abdominal radical hysterectomy group 
were significantly lower than those in the control group (P=0.02), with no significant differ-
ence between the abdominal radical trachelectomy and control groups. These data indicated 
that abdominal radical trachelectomy did not affect ovarian function with respect to ovarian 
reserve and the response to ovarian stimulation. 
Conclusions: Serum anti-Müllerian hormone levels could be useful as a marker of ovarian 
reserve after abdominal radical trachelectomy. It is important to avoid postoperative com-
plications causing a reduction in ovarian function to accomplish fertility-sparing surgery. 
Key words: abdominal radical trachelectomy, anti-Müllerian hormone, cervical cancer, fertility, 
ovarian reserve 
Introduction 
Cervical  cancer  is  the  second  most  common 
cancer  in  women  in  developing  countries  and  the 
seventh  in  developed  countries.  More  than  25%  of 
women with cervical cancer are under 40 years of age 
and the age of nulliparous women has increased in 
developed countries [1]. A total of 32% of women who 
were diagnosed at the early stage of cervical cancer 
were between the age of 20 and 39 years in our insti-
tution.  Moreover,  as  more  women  are  delaying 
child-bearing, preservation of fertility and reproduc-
tive function is a major concern when young women 
are counseled with regard to effects of treatment for 
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cervical  cancer.  Although  radical  hysterectomy  and 
radiotherapy  are  the  only  treatment  options  for 
women  with  invasive  cervical  cancer,  they  do  not 
spare fertility.  
To  tailor  treatment  to  provide  fertility-sparing 
options  without  compromising  oncologic  outcome, 
radical trachelectomy (RT) abdominally or vaginally 
coupled with pelvic lymph node dissection has been 
performed for over 20 years since first described by 
the French gynecologist Dargent in 1987  [2]. In our 
institution,  a  total  of  26  abdominal  RTs  were  per-
formed between 2006 and 2011.  
Plante et al. [3] followed up 125 women who had 
had RT with 106 pregnancies in 58 women but 13.5% 
had subfertility problems requiring assisted concep-
tion. Although it is well known that subfertility is due 
to isthmic stenosis with adhesion formation and a lack 
of cervical mucus to aid sperm migration, there are 
few reports on whether RT affects ovarian reserve and 
the response to controlled ovarian stimulation. 
Anti-Müllerian hormone (AMH) is a member of 
the transforming growth factor-β superfamily, which 
includes  several related peptides  including activins, 
inhibins  and  growth  differentiation  factors  [4].  In 
women, AMH is produced by granulosa cells, from 
pre-antral and antral follicles [5] and the main physi-
ological role of AMH in the ovary appears to be lim-
ited to inhibition of the early stages of follicular de-
velopment [6][7]. Recently, AMH has been evaluated 
by several groups as a potential novel clinical marker 
of ovarian reserve and of the response to gonadotro-
pins [8-18]. 
This study aimed to evaluate the effect of radical 
trachelectomy  on  ovarian  reserve  and  compared  it 
with  abdominal  radical  hysterectomy  (ARH)  and 
women who did not have surgery by measuring se-
rum AMH levels. 
Materials and Methods 
This study was approved by the institutional re-
view board at Hyogo Cancer Center. 
Patients 
A total of 26 abdominal radical trachelectomies 
(ARTs)  with  pelvic  lymphadenectomy  were  per-
formed in the department of Gynecologic Oncology at 
Hyogo Cancer Center from September 2006 to March 
2011.  
Our eligibility criteria for ART included the fol-
lowing: a desire to preserve fertility; a confirmed di-
agnosis  of  cervical  cancer;  localized  cancer  of  the 
uterine cervix; FIGO stage Ia to Ib1; a tumor size less 
than 2 cm; and no evidence of metastasis on preoper-
ative  pelvic  magnetic  resonance  imaging,  posi-
tron-emission tomography, and chest X-ray.  
Four patients needed to have hysterectomy be-
cause of per- or postoperative findings. One patient 
had severe pelvic lymphocyst infection with second-
ary  amenorrhea,  and  she  needed  to  have  complete 
resection of the uterus and drainage 9 months after 
ART. Three patients were moved to other hospitals. 
Therefore,  18  women  were  enrolled  for  this  retro-
spective study. To compare the level of AMH due to a 
difference  in  blood  supply,  we  enrolled  16  women 
who  had  abdominal  radical  hysterectomy  (ARH) 
performed  with  ovary  conservation  in  this  study. 
Data of serum AMH in 10,186 women of the control 
group were provided by the Japanese Institution for 
Standardizing  Assisted  Reproductive  Technology 
(JISART) group. Median age of control group is 36.1 
(range 25-47). 
Abdominal radical trachelectomy 
Laparotomy  and  a  complete  pelvic  lymphade-
nectomy were performed with a similar technique by 
undergoing a radical hysterectomy. All lymph nodes 
were sent for frozen section analysis. If lymph node 
metastasis was confirmed, ART was abandoned and 
we continued with radical hysterectomy. To preserve 
sufficient blood flow to the uterus, we identified the 
uterine  artery  and  cut  the  only  descending  branch. 
After  completing  resection  of  the  paracervical  soft 
tissues  including  the  parametria,  paracolpos,  and 
uterosacral  ligaments,  we  made  an  incision  in  the 
vaginal wall. The tumor extent was identified, and we 
separated the cervical tissue and parametria from the 
fundus. This specimen was sent for frozen sectioning 
to evaluate the endocervical and vaginal margin. If we 
confirmed a negative margin, the uterus was recon-
structed to the upper vagina using 1-0 polydioxanone 
suture.  
Hormonal measurement 
Serum AMH levels were measured at outpatient 
visits between November 2010 and July 2011. For two 
patients with ART, AMH levels were measured pre-
operatively upon enrollment and 1 day, 7 days and 3 
months  postoperatively.  Serum  AMH  levels  were 
measured  using  a  commercial  ELISA  kit  (ELISA 
AMH/MIS, SRL, Inc.).  
Statistical analysis 
Data analysis was performed with the software 
Stat  Mate  version  III  (ATMS,  Japan).  The 
Mann-Whitney  U  test  was  used  for  comparison  of 
patient characteristics and comparison of serum AMH 
levels  between  the  three  groups.  Fisher’s  exact  test 
was used for comparison of the relationship of post- Journal of Cancer 2012, 3 
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operative complications. The results were considered 
statistically significant at P<0.05. 
Results 
A total 34 patients were included in this study. 
Eighteen patients had ART performed and 16 patients 
had ARH performed. Their clinical characteristics are 
shown  in  Table  1.  There were  no  significant  differ-
ences in mean age, the period from the operation to 
blood  sampling,  and  body  mass  index  between  the 
two  groups.  Among  these  patients,  nobody  have 
polycystic ovaries and a history of infertility before 
operation and 32 out of 34 patients (94.1%, 16 in ART 
and 16 in ARH ) have a regular menstrual period after 
operation. One patient who received ART conceived 
naturally  and  delivered  by  cesarean  section  at  30 
weeks gestation. Mean (±SD) serum AMH levels were 
greater in the ART group (3.9±2.4 ng/ml) compared 
with  those  in  the  ARH  group  (2.4±1.9  ng/ml) 
(P<0.05). We compared serum AMH levels of the two 
groups with those of women who did not have sur-
gery as normal controls (Fig. 1). Serum AMH levels 
were not significantly different between the ART and 
control groups (P=0.49). However, serum AMH levels 
in the ARH group were significantly lower than those 
in  the  control  group  (P=0.02).These  data  indicated 
that ART did not affect ovarian function with respect 
to ovarian reserve and the response to ovarian stim-
ulation. There were eight women (8/18, 44.4%) whose 
serum  AMH  levels  were  lower  than  mean  normal 
control  values.  Among  them,  four  patients  had  a 
postoperative inclusion cyst in the pelvic area and one 
patient had secondary amenorrhea after ART (Table 
2). Ten women whose serum AMH levels were above 
mean  normal  control  levels  had  no  complications 
(P=0.022).  
 
Table 1. Patient characteristics 
  Radical tra-
chelectomy 
(18) 
Radical hyster-
ectomy 
(16) 
P 
value 
 
Age (years)  35.7±4.2  34.8±4.7  NS 
Duration after opera-
tion 
(months) 
27.2±12.2  32.5±16.2  NS 
BMI (kg/m2)  19.5±1.9  19.6±1.4  NS 
Blood loss (ml)  398.2±214  433.4±312  NS 
Operation time (min)  273.2±45.8  238.5±56.8  NS 
Values are mean ± SD. 
P values were calculated by the Mann-Whitney U-test. BMI = body 
mass index; NS = not significant. 
Table 2. Postoperative complications among the high AMH 
group (above average AMH levels of the control group) and 
low AMH group (below average AMH levels of the control 
group). 
  Inclusion cyst or 
amenorrhea 
No complications 
High AMH group  0  10 
Low AMH group  4  4 
 
 
 
 
 
 
 
Figure 1. Comparison of serum AMH levels between ART, ARH, 
and a control group of women who did not have surgery in rela-
tion to age.  
 
 
 
 
We then compared preoperative and postopera-
tive  serum  AMH  levels  between  two  women  with 
ART;  one  patient  had  an  uneventful  postoperative 
course  (ART-2)  and  the  other  patient  had  pelvic 
lymphocyst infection, which occurred 3 weeks after 
the  operation  (ART-1)  (Fig.  2).  Serum  AMH  levels 
were decreased the next day after surgery, and sub-
sequently  increased  after 1  week  postoperatively  in 
both  cases.  However,  serum  AMH  levels  of  ART-1 
were significantly decreased 90 days postoperatively. 
The decrease  in serum AMH levels may have been 
triggered by pelvic lymphocyst infection. 
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Figure 2. Effect of ART and ARH on serum AMH levels after the operation. preop = preoperation; POD = postoperative day 
 
Discussion 
Radical trachelectomy is a feasible procedure for 
young women with early-stage cervical cancer. VRT 
predominate as a fertility-sparing surgical procedure 
and  favorable  oncologic  and  obstetrical  outcomes 
were reported [3]. ART is a relatively new procedure 
and some studies have suggested that ART is feasible 
as a fertility-preserving procedure [19][20]. However 
it is major concern that women with ART were less 
likely to conceive than were women with VRT. It is 
presumed  that  the  causes  of  infertility  are  cervical 
problems, pelvic adhesion formation with a long op-
eration time, ischemia, excessive sutures, and altera-
tion of uterine and ovarian blood flow by resection of 
the uterine artery [20][21]. In our institution 78% of 
women  try  to  conceive  and  4  of  these  women  em-
ployed  assisted  reproductive  techniques.  However 
there was only one woman who conceived success-
fully and had a live birth. 
This is the first study that attempted to investi-
gate ovarian function after ART by measuring serum 
AMH  levels.  We  found  that  serum  AMH  levels  in 
patients  with  ART  were  significantly  higher  than 
those  of  patients  with  ARH.  In  our  institution,  to 
preserve sufficient blood flow to the uterus, we iden-
tified the uterine artery and cut the only descending 
branch. Because the ascending portion runs alongside 
the uterus and passes anterior to the ureter and anas-
tomoses with the ovarian artery, preservation of the 
uterine  ascending  arteries  may  contribute  to  the 
maintenance of ovarian function.  
When we compared preoperative and postoper-
ative serum AMH levels in two patients, we found 
transient postoperative reduction of serum AMH lev-
els 1 day after the operation and serum AMH levels 
gradually  recovered  7  days  after  the  operation. 
However,  serum  AMH  levels  were  even  more  de-
creased 3 months postoperatively in one patient who 
had  postoperative  pelvic  lymphocyst  infection.  Hi-
rokawa et al. found that the rate of decline in serum 
AMH  levels  showed  a  significant  correlation  to  the 
severity  of  endometriosis,  and  they  suggested  that 
endometrial cysts may cause negative effects on the 
surrounding tissue [22]. Therefore, postoperative in-
clusion cysts and pelvic infections are possible causes 
of  a  decline  in  serum  AMH  levels.  We  performed 
radical  trachelectomy  for  early  cervical  cancer  pa-
tients to preserve fertility. Iatrogenic secondary infer-
tilities  caused  by  surgical  procedures  should  be 
avoided.  Therefore,  postoperative  complications 
should be avoided to restore the ovarian reserve.  
Unfortunately preoperative AMH level were not 
shown in this study, however we could demonstrated 
that serum AMH levels were not significantly differ-
ent between the ART and control groups. The purpose 
of  performing  ART  for  early  cervical  cancer  is  not 
only  to  achieve  a  definitive  surgery,  but  also  to 
achieve  pregnancy  after  surgery.  AMH  levels  lsess 
than 0.7ng/ml has been proposed for identification of 
poor responders of IVF [18][23], women whose pre-
operative  AMH  levels  were  identified  low  levels  
recommend to perform ARH better than ART. 
In conclusion, we found that serum AMH levels 
in patients with ART were significantly higher than 
those in patients with ARH. However, postoperative 
inclusion cysts or pelvic infections are associated with 
a decreased ovarian reserve. Our study suggests that  Journal of Cancer 2012, 3 
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serum  AMH  levels  could  be  useful  as  a  marker  of 
ovarian reserve after ART and that it is necessary to 
avoid  postoperative  complications  causing  a  reduc-
tion  in  ovarian  function  to  accomplish  fertili-
ty-sparing surgery. 
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